Proteomic-Based Discovery and Characterization of Glycosylated Eosinophil-Derived Neurotoxin and COOH-Terminal Osteopontin Fragments for Ovarian Cancer in Urine
Open Access
- 15 January 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (2) , 432-441
- https://doi.org/10.1158/1078-0432.ccr-05-0461
Abstract
Purpose: The objective was to identify and characterize low molecular weight proteins/peptides in urine and their posttranslational modifications that might be used as a screening tool for ovarian cancer.Keywords
This publication has 41 references indexed in Scilit:
- Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian CancerCancer Research, 2004
- Bone Sialoprotein, Matrix Metalloproteinase 2, and v 3 Integrin in Osteotropic Cancer Cell InvasionJNCI Journal of the National Cancer Institute, 2004
- Three small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinasesThe FASEB Journal, 2004
- Monitoring the allergic inflammationAllergy, 2003
- Turning Sweet on CancerScience, 2003
- Degranulating Eosinophils in Human EndometriosisThe American Journal of Pathology, 2000
- Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinomaCancer, 2000
- Two‐dimensional electrophoresis of human urinary proteins following concentration by dye precipitationElectrophoresis, 1996
- Overcoming obstacles to metastasis ‐ defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cellsJournal of Cellular Biochemistry, 1994
- A putative mouse oocyte maturation inhibitory protein from urine of pregnant women: N-terminal sequence homology with human nonsecretory ribonuclease.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991